weldinin
egis pharmaceuticals plc, maďarsko - sorafenib - 44 - cytostatica
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastické činidlá - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
sorafenib sandoz 400 mg
sandoz pharmaceuticals d.d., slovinsko - sorafenib - 44 - cytostatica
sorafenib pharmagen
pharmagen cz s.r.o., Česká republika - sorafenib - 44 - cytostatica
controloc 20 mg gastrorezistentné tablety
takeda gmbh, nemecko - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
ozzion 40 mg gastrorezistentné tablety
zentiva, k.s., Česká republika - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
ozzion 20 mg gastrorezistentné tablety
zentiva, k.s., Česká republika - pantoprazol - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinálne stromálne nádory - iné antineoplastické činidlá, protein kinase inhibítory - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
pantecta control
takeda gmbh - pantoprazol - gastroezofageálny reflux - protónovej pumpy inhibítory - krátkodobá liečba príznakov refluxu (napr. pálenie záhy, kyslé regurgitácia) u dospelých.
xefo rapid
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica